Equillium, Inc.
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clin…
Biotechnology
US, La Jolla [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Equillium, Inc. (EQ) to it's peer group.
Peer Group
MNPR LIFE JSPR IKNA CVKD CUE HOOK TRVI SPRO HOWL NLTX LIAN EWTX BOLT KTTA ANEB SABS QNRX BCAB ANTX LYRA CHRS
Compare Together
Loading...